News

Zacks Investment Research on MSN1d
Netlist, Inc. (NLST) Reports Q2 Loss, Beats Revenue Estimates
Netlist, Inc. (NLST) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.06 per share a year ago. These figures are adjusted for ...
Eli Lilly raises full-year profit forecast on weight-loss drug strength
Eli Lilly raised its full-year profit forecast on Thursday, betting on surging demand for its blockbuster weight-loss drug, Zepbound, as it targets new markets and looks to grab more share from Novo ...
Lilly raises full-year earnings forecasts on surging demand for weight-loss drug
Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster ...